Private company
Who owns Generate Biomedicines, Inc.
One company in the researched set discloses a stake in Generate Biomedicines, Inc., worth $14m between them. Generate Biomedicines, Inc. is private, so no 13F reports it: a 13F covers exchange listed positions only. These figures exist because each holder disclosed the stake in its own filings.
Generate Biomedicines, Inc. - Profile
- Type
- private company
- Based in
- United States
- Founded
- 2018
Generate Biomedicines is a clinical stage biotechnology company in Somerville, Massachusetts, created in 2018 inside the venture firm Flagship Pioneering. It applies machine learning models trained on protein structures and genetic sequence data to design new therapeutic proteins, running a generate, build, measure and learn cycle that produces antibodies, peptides, enzymes and cytokines aimed at specific disease targets rather than screening existing molecules. Its programs span immunology, oncology and infectious disease, led by GB-0895, an anti TSLP antibody engineered for six month dosing that is in Phase 3 trials in severe asthma and a Phase 1b trial in COPD, alongside GB-4362 in oncology, which carries FDA Fast Track designation. The company has partnered with Amgen, the MD Anderson Cancer Center and Novartis, and it listed on Nasdaq under the ticker GENB in February 2026, raising 400 million dollars.
Source
Generate Biomedicines, Inc. files nothing with the SEC, so none of this comes from a filer record. The description was written for this site in August 2026 from Generate:Biomedicines Announces Close of $273M Series C Financing, Generate:Biomedicines, Wikipedia and Generate Biomedicines' IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug, MedCity News. The ownership figures below come from the holders' filings instead, and are sourced row by row.
The disclosed stakes
One row per position. Where a holder reports the same company in two share classes, both rows are shown rather than summed, because the class is part of a position's identity.
Where each figure comes from
A private stake has no ownership form behind it, so the source is always the holder's own filing or disclosure. Anything modelled says so, with the arithmetic.
- NVIDIA Corporation, as of 30 Jun 2026. Smallest of the eight 13F positions. Its presence in a 13F means it is a section 13(f) reportable security, so it is treated here as not private, but no ticker and no share count for the issuer were confirmed in this task, so the percentage of target is left null. CUSIP 370920100. source
What this page is not
It is not a complete register. It lists the holders who happen to be inside the researched set and disclosed the stake themselves. A private company can have many other shareholders, and nothing here rules them out: venture investors, founders and employees usually appear in no public filing at all. Percentages are of Generate Biomedicines, Inc. where a holder stated one, and are missing where no holder did.